Last Updated on: 12th September 2024, 11:40 pm
It's Ginevra's second stem cell treatment for Optic Nerve Hypoplasia/Septo Optic Dysplasia. After the first treatment, she experienced significant improvements in her visual and motor conditions over three months. Previously unable to perceive light, Ginevra can now follow it and has started to walk.
According to her family, Beike's treatment—which included four lumbar and four intravenous injections supplemented with growth factor for nerve growth—was administered smoothly and with minimal pain by a professional nursing team. During the first round, Ginevra began to distinguish colors and take her first steps.
The expectation for the second treatment is further improvements in distance vision and object perception. Watch the full video to hear her family's insights.